sitagliptin
sitagliptin: 4 clinical trials tracked.
sitagliptin evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
What is verified about sitagliptin, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence6 indications · 2 study sponsors
Clinical Trial Registry Records (4)
A Phase 1 Study to Evaluate the Effect of Multiple Doses of ABBV-722 on the Pharmacokinetics of Cocktail Probe Substrates of CYP3A and Select Transporters in Healthy Adult Subjects
Primary endpoint: Number of Participants with Adverse Events (AEs)
Comparative Effectiveness of Dulaglutide, Semaglutide, and Tirzepatide in Preventing Cardiovascular Events in Patients With Type 2 Diabetes and Obesity With or Without Atherosclerotic Cardiovascular Disease.
Primary endpoint: Composite of myocardial infarction, stroke, or all-cause mortality.
The GLP-1 Agonist Semaglutide for the Treatment of Metabolic Disease in Liver Transplant Recipients: A Phase IV, Randomized Trial
Primary endpoint: Change in HbA1c level
Phase 2, Randomized, Double-Blind, Placebo and Active-Comparator Controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes
Primary endpoint: Evaluate the effect of MBX-2982 on the absolute and percent change from baseline and placebo in mean weighted average of 14-point blood glucose levels associated with a standardized breakfast and lunch